ABSTRACT
Objetivo: Describir y clasificar los errores en la formulación de quimioterapia de oncología, hematología y pediatría. Métodos: Estudio de corte transversal, mediante un muestreo en un periodo de tiempo. Las formulaciones seleccionadas fueron evaluadas y clasificadas según tipo de error y se verificó en la historia clínica la existencia de efectos asociados a los pacientes. Resultados: Se revisaron 440 formulaciones y se identificaron 54 errores. El tipo de error más frecuente fue el relacionado con la prescripción y con la capacidad de causar lesión. De los errores identificados 17 ocasionaron efectos o lesiones en los pacientes que no produjeron muertes o discapacidades. La ciclofosfamida, el trastuzumab y la dexametasona fueron los medicamentos que más se asociaron con la mayoría de errores. Discusión: La frecuencia calculada de errores fue comparable con la publicada en la literatura. Los errores identificados son potencialmente evitables, pero se requiere diseñar programas enfocados a su prevención que incluya acciones educativas dirigidas a especialistas, químicos farmacéuticos, enfermeras y pacientes.
Objectives: To describe and classify the medication errors that occurred during a 6 months period in oncology, hematology and pediatrics. Methods: A cross-sectional study was conducted using a 6 month time period sample. The formulations selected were evaluated and classified according to error type, and the existence of patient-related effects were verified in the clinical notes. Findings: A total of 440 formulations were reviewed and 54 errors (12.3%) were identified, with the most frequent being related to prescription. The severity of these errors was potentially harmful. A total of 17 adverse events were identified in patients, and were not associated with deaths or disabilities. Cyclophosphamide, trastuzumab, dexamethasone, among others, were associated with most errors. Discussion: The overall error rate found is comparable with those in the world literature. Despite the complexity of the prescription, these errors remain avoidable, but a prevention program is needed that focuses on educational activities with participation by specialists, pharmaceutical chemists, nurses, as well as patients. © 2014 Instituto Nacional de Cancerología. Published by Elsevier España, S.L.U. All rights reserved.
Subject(s)
Humans , Drug Therapy , Medication Errors , Time , Dexamethasone , Pharmaceutical Preparations , Medical Records , Cyclophosphamide , TrastuzumabABSTRACT
Objetivo: obtener información sobre el desempeño de las instituciones prestadoras de servicios de Salud (IPS) oncológicas. Materiales y métodos: estudio descriptivo mediante encuestas.Resultados: de un total de 73 formularios remitidos a las IPS con servicios oncológicos habilitadosy a las empresas sociales del Estado (ESE) de segundo nivel, se recibieron 42 (57,5 %). Se evaluaron actividades de consulta externa y se calculó la oferta teórica y la disponibilidaddel talento humano. Se describen los servicios que cuentan con servicio de hospitalización para pacientes oncológicos y se valoran procedimientos diagnósticos en cáncer, aspectos detratamiento y seguimiento. Conclusiones: los servicios oncológicos en Bogotá son en su gran mayoría privados. Se evidencia una falta de integración entre las especialidades. La oferta de servicios actualmente disponible debería ser suficiente para las necesidades presentes, con laexcepción del servicio de cirugía gastrointestinal oncológica...
The objective of this study was to obtain information on the performance of the oncological Health Service Providing Institutions (IPS per their initials in Spanish). The method used wasa descriptive study based on surveys. We found that of every 73 forms sent to IPS with enabled oncology services and to Level II State Social Enterprises (ESE per their initials in Spanish), 42 were returned (57.5%). We evaluated outpatient activities and calculated the theoretical supply and the availability of human resources. The facilities that have inpatient service for cancer patients were described and their cancer diagnostic procedures, treatment and monitoring aspects were assessed. The results of the study showed that cancer services in Bogotá are mostly private, that there is a lack of integration between the specialties and that the range of services currently available should be sufficient for present needs, except for gastrointestinalcancer surgery service...
Objetivo: Obter informações sobre o desempenho das instituições que prestam serviços de saúde (IPS) em oncologia. Materiais e métodos: estudo descritivo mediante inquérito. Resultados: De um total de setenta y três formulários enviados à IPS habilitadas para atendimento em oncologia e às empresas sociais do estado (ESE) de segundo nível, foram recebidas 42 (57,5%). Foram avaliadas as atividades ambulatoriais e calculada a oferta teórica e disponibilidade de talento humano. Descrevem-se os serviços que têm o serviço de internação para pacientes com câncer eavaliam-se procedimentos de diagnóstico de câncer, e aspectos de tratamento y monitoramento.Conclusões: Serviços de câncer em Bogotá são majoritariamente privados. É evidente uma falta de integração entre especialidades. A gama de serviços actualmente disponíveis deveráser suficiente para as necessidades actuais, com excepção do serviço de cirurgia gastrointestinal oncológica...